For those who maintained consistent GLP-1 use, medical cost growth was six to nine percentage points lower compared to non-users, and female GLP-1 users saw a 47% reduction in hospitalizations for major cardiovascular events
Thus, it is feasible that even if there may be a tumor-promoting effect that the duration of drug exposure may not be sufficient to significantly increase the risk of tumorigenesis
If retatrutide is approved in the UK and youre already taking Mounjaro, switching would normally involve stopping Mounjaro, allowing a washout period of one week, and starting retatrutide at an equivalent dose
Tissue Engineering and Regenerative Medicine, 17 (3), 323333
Despite a pipeline that ranks fifth in Europe, according to another report by SwedenBIO, biopharmaceutical companies in the country have not been able to match the funding levels of their European peers. -: